More investors than ever want their money to make a positive impact on the world while producing a financial return. Reboot Rx’s CEO Laura Kleiman recently moderated the “Investing for Social Impact” panel at the WuXi Global Forum. She shares reflections on how impact investing could fund clinical trials testing new uses for generic drugs.